These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11289158)

  • 21. Beta-catenin/T-cell factor-mediated transcription is modulated by cell density in human bronchial epithelial cells.
    Steel MD; Puddicombe SM; Hamilton LM; Powell RM; Holloway JW; Holgate ST; Davies DE; Collins JE
    Int J Biochem Cell Biol; 2005 Jun; 37(6):1281-95. PubMed ID: 15778091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transactivation of vimentin by beta-catenin in human breast cancer cells.
    Gilles C; Polette M; Mestdagt M; Nawrocki-Raby B; Ruggeri P; Birembaut P; Foidart JM
    Cancer Res; 2003 May; 63(10):2658-64. PubMed ID: 12750294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Tcf4 residues involved in high-affinity beta-catenin binding.
    Omer CA; Miller PJ; Diehl RE; Kral AM
    Biochem Biophys Res Commun; 1999 Mar; 256(3):584-90. PubMed ID: 10080941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin.
    Bordonaro M; Mariadason JM; Aslam F; Heerdt BG; Augenlicht LH
    Cell Growth Differ; 1999 Oct; 10(10):713-20. PubMed ID: 10547075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
    Jung HC; Kim K
    Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
    Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
    Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [beta-catenin overexpression in metastasized colorectal carcinoma--an important mechanism in progression of the disease?].
    Mann B; Gratchev A; Riede E; Schmidt-Wolf I; Trojanek B; Moyer P; Hanski C; Buhr HJ
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):303-6. PubMed ID: 14518265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
    Chen RH; McCormick F
    Cancer Res; 2001 Jun; 61(11):4445-9. PubMed ID: 11389074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer.
    Dimberg J; Hugander A; Sirsjö A; Söderkvist P
    Anticancer Res; 2001; 21(2A):911-5. PubMed ID: 11396184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas.
    Fujita M; Furukawa Y; Tsunoda T; Tanaka T; Ogawa M; Nakamura Y
    Cancer Res; 2001 Nov; 61(21):7722-6. PubMed ID: 11691783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
    Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
    Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development.
    Schmidt M; Patterson M; Farrell E; Münsterberg A
    Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions.
    Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A
    Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?
    Gad S; Teboul D; Lièvre A; Goasguen N; Berger A; Beaune P; Laurent-Puig P
    BMC Cancer; 2004 Jul; 4():31. PubMed ID: 15245581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
    Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
    Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study on the formation of specialized inter-Sertoli cell junctions in vitro.
    Chung SS; Lee WM; Cheng CY
    J Cell Physiol; 1999 Nov; 181(2):258-72. PubMed ID: 10497305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.
    Liu W; Dong X; Mai M; Seelan RS; Taniguchi K; Krishnadath KK; Halling KC; Cunningham JM; Boardman LA; Qian C; Christensen E; Schmidt SS; Roche PC; Smith DI; Thibodeau SN
    Nat Genet; 2000 Oct; 26(2):146-7. PubMed ID: 11017067
    [No Abstract]   [Full Text] [Related]  

  • 39. Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/beta-catenin complex.
    Idogawa M; Yamada T; Honda K; Sato S; Imai K; Hirohashi S
    Gastroenterology; 2005 Jun; 128(7):1919-36. PubMed ID: 15940627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration.
    Mahmoud NN; Boolbol SK; Bilinski RT; Martucci C; Chadburn A; Bertagnolli MM
    Cancer Res; 1997 Nov; 57(22):5045-50. PubMed ID: 9371501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.